INCIDENCE AND RISK FACTORS FOR ORAL MUCOSITIS AFTER BONE MARROW TRANSPLANTATION PATIENTS UNDER LOW INTENSITY LASER THERAPY: A LONGITUDINAL STUDY

Authors

  • Cassia Emanuella Nobrega Malta Department of Dental Clinic, Division of Oral Pathology, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceará, Fortaleza, Ceará, Brazil
  • Maria Imaculada de Queiroz Rodrigues Department of Dental Clinic, Division of Oral Pathology, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceará, Fortaleza, Ceará, Brazil
  • José Vitor de Mota Lemos Post-graduate program in Dental Sciences, Unichristus, Fortaleza, Brazil
  • Natalia Costa Bezerra Freire Nurse Coordinator of the Bone Marrow Transplant Unit at the University Hospital Walter Cantídio (HUWC)
  • Fernando Barroso Duarte Postdoctoral fellow at the Fred Hutchinson Cancer Research Center (Fred Hutch), Head of the Hematology, Clinical Oncology and Bone Marrow Transplant Department at the Hospital Universitário Walter Cantídio/EBSERH /UFC, responsible for the implantation of the bone marrow transplant in Ceará, Member of the editorial board of the Latin American Bone Marrow Transplantation
  • Paulo Goberlânio de Barros Silva Department of Dental Clinic, Division of Oral Pathology, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceará, Fortaleza, Ceará, Brazil
  • Ana Paula Negreiros Nunes Alves Department of Dental Clinic, Division of Oral Pathology, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceará, Fortaleza, Ceará, Brazil

DOI:

https://doi.org/10.46765/2675-374X.2020v2n1p44-54

Keywords:

Hematopoietic Stem Cell Transplantation; Mucositis; Low Intensity Light Therapy

Abstract

Bone marrow transplantation (BMT) has been used to treat numerous malignant and non-malignant hematological diseases, genetic and immunological diseases with a high risk of oral mucositis (OM) due to the action of antineoplastic drugs. As photobiomodulation therapy (FBMT) with low-level laser is a proven non-invasive treatment for OM, the objective of this study was to evaluate the incidence of OM in patients on BMT undergoing FBM. 53 patients undergoing treatment received FBMT (red laser, 2J, 20s, 100mW) as a preventive protocol. If MO was observed, an infrared laser (4J, 40s, 100W) was administered. The following data were collected from patients' medical records: sex, age, chemotherapy protocol (QT) and type of BMT. An incidence of 34% was observed in the population studied (20% grade I, 11.3% grade II and 1.9% grade III). Prevention protocols using FBMT significantly reduced the incidence of oral mucositis (p = 0.004). Now, young patients with myeloid leukemia, the time between QT and BMT (p = 0.010) and time of QT (p = 0.018) were directly associated with the increased incidence of oral mucositis. It was concluded that low-intensity preventive laser therapy was associated with a reduction in the incidence of oral mucositis, showing the importance of this therapy in the management of patients undergoing BMT.

Downloads

Published

10/14/2020

How to Cite

Malta, C. E. N., Rodrigues, M. I. de Q., Lemos, J. V. de M., Freire, N. C. B., Duarte, F. B., Silva, P. G. de B., & Alves, A. P. N. N. (2020). INCIDENCE AND RISK FACTORS FOR ORAL MUCOSITIS AFTER BONE MARROW TRANSPLANTATION PATIENTS UNDER LOW INTENSITY LASER THERAPY: A LONGITUDINAL STUDY. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 1(3), 44–54. https://doi.org/10.46765/2675-374X.2020v2n1p44-54

Issue

Vol. 1 No. 3 (2020): Journal of Bone Marrow Transplantation and Cellular Therapy

Section

Original article

Most read articles by the same author(s)

1 2 3 > >>